[go: up one dir, main page]

ZA945657B - Method to inhibit restenosis - Google Patents

Method to inhibit restenosis

Info

Publication number
ZA945657B
ZA945657B ZA945657A ZA945657A ZA945657B ZA 945657 B ZA945657 B ZA 945657B ZA 945657 A ZA945657 A ZA 945657A ZA 945657 A ZA945657 A ZA 945657A ZA 945657 B ZA945657 B ZA 945657B
Authority
ZA
South Africa
Prior art keywords
inhibit restenosis
restenosis
inhibit
Prior art date
Application number
ZA945657A
Other languages
English (en)
Inventor
G Michael Vincent
Patricia M Logan
Original Assignee
Quadra Logic Tech Inc
G Michael Vincent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc, G Michael Vincent filed Critical Quadra Logic Tech Inc
Publication of ZA945657B publication Critical patent/ZA945657B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Control Of Eletrric Generators (AREA)
ZA945657A 1993-07-29 1994-07-29 Method to inhibit restenosis ZA945657B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/099,210 US5422362A (en) 1993-07-29 1993-07-29 Method to inhibit restenosis

Publications (1)

Publication Number Publication Date
ZA945657B true ZA945657B (en) 1996-01-29

Family

ID=22273603

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945657A ZA945657B (en) 1993-07-29 1994-07-29 Method to inhibit restenosis

Country Status (13)

Country Link
US (1) US5422362A (xx)
EP (1) EP0711161A4 (xx)
JP (1) JP3146009B2 (xx)
KR (1) KR100256853B1 (xx)
CN (1) CN1127991A (xx)
AU (1) AU684301B2 (xx)
CA (1) CA2168043A1 (xx)
FI (1) FI960398A0 (xx)
IL (1) IL110455A0 (xx)
NO (1) NO960339L (xx)
PL (1) PL312796A1 (xx)
WO (1) WO1995003797A1 (xx)
ZA (1) ZA945657B (xx)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
US6107325A (en) * 1995-01-17 2000-08-22 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US6096776A (en) * 1995-01-17 2000-08-01 Qlt Phototherapeutics, Inc. Green porphyrins as immunomodulators
US5707608A (en) * 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
US5948771A (en) * 1996-01-31 1999-09-07 The Trustees Of Columbia University In The City Of New York Method for treating heart failure using tetrapyrroles and metallotetrapyrroles
US5834503A (en) * 1996-06-14 1998-11-10 Qlt Phototherapeutics, Inc. Methods to treat arterial plaque
US6043237A (en) * 1996-12-10 2000-03-28 Qlt Phototherapeutics, Inc. Use of photodynamic therapy for prevention of secondary cataracts
DE69824853T2 (de) 1997-02-11 2006-01-12 Qlt Inc., Vancouver Zusammensetzung und Gegenstände zur Verminderung der Auswirkung von Entzündungen
US6274614B1 (en) * 1997-02-11 2001-08-14 Qlt Inc. Methods, compositions and articles for reducing or preventing the effects of inflammation
US6488673B1 (en) * 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US6634363B1 (en) 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US7027869B2 (en) 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US5902299A (en) * 1997-07-29 1999-05-11 Jayaraman; Swaminathan Cryotherapy method for reducing tissue injury after balloon angioplasty or stent implantation
WO1999030641A1 (en) 1997-12-15 1999-06-24 Prolifix Medical, Inc. Vascular stent for reduction of restenosis
AU746857B2 (en) 1997-12-19 2002-05-02 United States Surgical Corporation Fibrin mixture and dispenser assembly
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US20070106348A1 (en) * 1998-06-10 2007-05-10 Asthmatx, Inc. Method for treating airways in the lung
US7198635B2 (en) 2000-10-17 2007-04-03 Asthmatx, Inc. Modification of airways by application of energy
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
WO2000059505A1 (en) * 1999-04-02 2000-10-12 Meiji Seika, Kaisha, Ltd. Inhibitors for vascular reconstriction after angioplasty
US6609014B1 (en) * 1999-04-14 2003-08-19 Qlt Inc. Use of PDT to inhibit intimal hyperplasia
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
US7122568B1 (en) * 1999-11-17 2006-10-17 Qlt, Inc. Use of low-dose PDT to inhibit restenosis
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US7104987B2 (en) 2000-10-17 2006-09-12 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
WO2002064163A2 (en) 2001-02-15 2002-08-22 Qlt Inc. Reduction or prevention of pdt related inflammation
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
EP1401479B1 (en) * 2001-06-04 2007-04-18 The General Hospital Corporation Detection and therapy of vulnerable plaque with photodynamic compounds
JP3990972B2 (ja) 2001-11-20 2007-10-17 有限会社 キック 血管再狭窄防止薬及び該防止薬がコーティングされた血管内埋め込み器具
US6783541B2 (en) 2001-11-21 2004-08-31 Miravant Medical Technologies, Inc. Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts
US6821289B2 (en) * 2003-03-25 2004-11-23 Ceramoptec Industries, Inc. Efficacy and safety of photodynamic therapy by multiple application protocols with photosensitizers that show extended tumor retention
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US20080193376A1 (en) * 2004-10-28 2008-08-14 The General Hospital Corporation Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
WO2009137819A1 (en) 2008-05-09 2009-11-12 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
NZ602592A (en) 2008-07-28 2014-01-31 Takeda Pharmaceutical Light irradiation resistant pharmaceutical composition
CN104042322B (zh) 2009-10-27 2017-06-06 赫莱拉公司 具有可冷却的能量发射组件的递送装置
CA2780608C (en) 2009-11-11 2019-02-26 Innovative Pulmonary Solutions, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
WO2013184319A1 (en) 2012-06-04 2013-12-12 Boston Scientific Scimed, Inc. Systems and methods for treating tissue of a passageway within a body
WO2014018153A1 (en) 2012-07-24 2014-01-30 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
WO2014071372A1 (en) 2012-11-05 2014-05-08 Boston Scientific Scimed, Inc. Devices for delivering energy to body lumens
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
CN110547865B (zh) 2013-08-09 2022-10-04 波士顿科学国际有限公司 可扩张导管以及制造和使用的相关方法
CA3064782A1 (en) * 2017-05-26 2018-11-29 Altum Pharmaceuticals Inc. Biphasix cannabinoid delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5002962A (en) * 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5308608A (en) * 1989-06-07 1994-05-03 University Of British Columbia Photosensitizing Diels-Alder porphyrin derivatives
US5214036A (en) * 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy
US5116864A (en) * 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
JP3154742B2 (ja) * 1991-04-30 2001-04-09 日本石油化学株式会社 哺乳類の動脈硬化症治療剤

Also Published As

Publication number Publication date
IL110455A0 (en) 1994-10-21
FI960398A0 (fi) 1996-01-29
EP0711161A4 (en) 1997-07-30
US5422362A (en) 1995-06-06
CN1127991A (zh) 1996-07-31
KR960703585A (ko) 1996-08-31
AU7401794A (en) 1995-02-28
JP3146009B2 (ja) 2001-03-12
NO960339L (no) 1996-03-26
NO960339D0 (no) 1996-01-26
EP0711161A1 (en) 1996-05-15
AU684301B2 (en) 1997-12-11
CA2168043A1 (en) 1995-02-09
KR100256853B1 (ko) 2000-05-15
WO1995003797A1 (en) 1995-02-09
JPH09503998A (ja) 1997-04-22
PL312796A1 (en) 1996-05-13

Similar Documents

Publication Publication Date Title
ZA945657B (en) Method to inhibit restenosis
EP0701436A4 (en) PROCESS
GB9306409D0 (en) Process
GB9305902D0 (en) Process
GB9309458D0 (en) Process
GB9305142D0 (en) Method
GB9313723D0 (en) Process
GB9302331D0 (en) Process
GB9307245D0 (en) Process
GB9303770D0 (en) Process
GB9306292D0 (en) Method
GB9300309D0 (en) Process
GB9315081D0 (en) Process
GB9323819D0 (en) Anlytical method
GB9302302D0 (en) Process
ZA947533B (en) Process i
IL106203A0 (en) Plant micropropagations
GB9325547D0 (en) Pesticidial method
GB9321930D0 (en) Method
GB9301636D0 (en) Method
GB9312936D0 (en) Method
GB9319051D0 (en) Method
GB9323939D0 (en) Method
ZA947534B (en) Process ii
GB9307246D0 (en) Process